- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07838025
AirGo™ Respiratory Monitoring in Lung Resection
Perioperative Real-time Respiratory Assessment in Lung Resections With a New Device: the AirGoTM System
Patients undergoing lung resection surgery may experience changes in respiratory function during the perioperative period. Current monitoring methods provide important clinical information but are often limited to specific time points and may not allow continuous assessment of ventilation. This study aims to evaluate the feasibility and usefulness of the AirGo™ wearable respiratory monitoring system in patients undergoing anatomical lung resection (lobectomy or segmentectomy). AirGo™ is a non-invasive, CE-marked device that continuously measures respiratory parameters, including minute ventilation and respiratory rate, through a chest-worn sensor. Participants will wear the AirGo™ device before surgery and during the postoperative period. Respiratory parameters collected by AirGo™ will be analyzed at predefined time points and compared with standard clinical monitoring methods routinely used in postoperative care, including pulse oximetry and telemetry. The primary objective is to assess changes in mean minute ventilation from the preoperative period to the first postoperative day. Secondary objectives include evaluating perioperative respiratory trends, patient comfort and compliance with the device, and the agreement between AirGo™ measurements and standard monitoring systems. The results of this study may help determine whether continuous non-invasive respiratory monitoring can improve the assessment and management of patients undergoing lung surgery.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Lombardy
-
Pavia, Lombardy, Italy, 27100
- Recruiting
- Fondazione IRCCS Policlinico San Matteo di Pavia
-
Contact:
- Arianna Farronato, MD
- Phone Number: 0382503515 0382-503521
- Email: a.farronato@smatteo.pv.it
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Patients scheduled for minimally invasive anatomical lung resection, specifically Video-Assisted thoracic surgery (VATS) lobectomy or segmentectomy, performed for diagnostic or curative purposes;
- Patients capable of performing a spirometry
- Age between 21 and 80 years
- Patient consented to the study by signing the consent
Exclusion Criteria:
- Pre-operative presence of pneumothorax and/or pleural effusion
- Pregnancy
- Severe trauma or major surgery in the last year previous cardio-thoracic surgery (including spinal surgery)
- Preoperative chest pain or low back pain,
- Obesity (BMI >30)
- Emergency surgery
- Patients scheduled for anatomical lung resection
- Specifically thoracotomy lobectomy or segmentectomy
- Scheduled bi-lobectomy or pneumonectomy or extended sleeve lobectomy
- Lung resection extended to the chest wall
- Inability to follow procedures
- Insufficient knowledge of project language (italian)
- Inability to give consent
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: AirGo Respiratory Monitoring
Participants undergoing minimally invasive anatomical lung resection (VATS, lobectomy or segmentectomy) will undergo perioperative respiratory monitoring using the AirGo™ device in addition to standard clinical care. Respiratory parameters, including minute ventilation and respiratory rate, will be assessed at predefined timepoints before and after surgery. |
AirGo™ is a non-invasive wireless wearable respiratory monitoring system used for continuous measurement of respiratory parameters, including minute ventilation and respiratory rate, during the perioperative period. |
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in Mean Minute Ventilation
Time Frame: From preoperative baseline to the first postoperative day
|
Difference in mean minute ventilation (L/min), measured by the AirGo™ system during a 60-minute resting recording, between the preoperative assessment and the first postoperative day. |
From preoperative baseline to the first postoperative day
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in Mean Minute Ventilation Over Perioperative Timepoints
Time Frame: Preoperative baseline, first postoperative day, second postoperative day, and one month after intervention
|
Change in mean minute ventilation (L/min) measured by the AirGo™ system at preoperative baseline, first postoperative day, second postoperative day, and one month after surgery |
Preoperative baseline, first postoperative day, second postoperative day, and one month after intervention
|
|
Change in Mean Resting Respiratory Rate
Time Frame: Preoperative baseline, first postoperative day, second postoperative day, and one month after intervention
|
Change in mean resting respiratory rate (breaths/min) measured by continuous AirGo™ monitoring at preoperative baseline, first postoperative day, second postoperative day, and one month after surgery. |
Preoperative baseline, first postoperative day, second postoperative day, and one month after intervention
|
|
Patient-Reported Comfort With AirGo™ Monitoring
Time Frame: During the postoperative period
|
Patient-reported comfort during AirGo™ monitoring assessed using a standardized Numerical Rating Scale (NRS) |
During the postoperative period
|
|
Agreement Between AirGo™ and Standard Postoperative Monitoring for Respiratory Rate
Time Frame: During the postoperative monitoring period on postoperative days 1 and 2
|
Agreement between respiratory rate measured by the AirGo™ system and respiratory rate obtained from standard postoperative monitoring, including pulse oximetry and telemetry, during overlapping observation periods. |
During the postoperative monitoring period on postoperative days 1 and 2
|
|
AirGo™ Device-Related Adverse Events
Time Frame: From device application through 1 month after intervention
|
Number of participants experiencing device-related adverse events, including skin irritation, discomfort, interference with surgical wounds, and premature discontinuation of monitoring. |
From device application through 1 month after intervention
|
Collaborators and Investigators
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- AirGoLR
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.